Modifying enzymes related aminoglycoside: analyses of resistant Acinetobacter isolates
- PMID: 25932248
- PMCID: PMC4402895
Modifying enzymes related aminoglycoside: analyses of resistant Acinetobacter isolates
Abstract
Enzymatic modification of aminoglycosides by nucleotidyltransferases, acetyltransferases and/or phosphotransferases accounts for the majority of aminoglycoside-resistant Acinetobacter isolates. In this study, we investigated the relationship between aminoglycoside resistance and the presence of aminoglycoside-modifying enzymes in Acinetobacter baumannii clinical isolate groups with different resistance profiles. Thirty-two clinical A. baumannii isolates were included in this study. Acinetobacter isolates were divided into 4 groups according to results of susceptibility testing. The presence of genes encoding the following aminoglycoside-modifying enzymes; aph (3')-V1, aph (3')-Ia, aac (3)-Ia, aac (3) IIa, aac (6')-Ih, aac (6')-Ib and ant (2')-Ia responsible for resistance was investigated by PCR in all strains. The acetyltransferase (aac (6')-Ib, aac (3)-Ia) and phosphotransferase (aph (3')-Ia) gene regions were identified in the first group, which comprised nine imipenem, meropenem, and gentamicin-resistant isolates. The acetyltransferase (aac (6')-Ib, aac (3)-Ia), phosphotransferase (aph (3')-VI) and nucleotidyltransferase (ant2-Ia) gene regions were identified in the second group, which was composed of nine imipenem-resistant, meropenem-resistant and gentamicin-sensitive isolates. The acetyltransferase (aac (3)-Ia) and phosphotransferase (aph (3')-Ia) regions were identified in the fourth group, which comprised eight imipenem-sensitive, meropenem-sensitive and gentamicin-resistant isolates. Modifying enzyme gene regions were not detected in the third group, which was composed of six imipenem, meropenem and gentamicin-sensitive isolates. Our data are consistent with previous reports, with the exception of four isolates. Both acetyltransferases and phosphotransferases were widespread in A. baumannii clinical isolates in our study. However, the presence of the enzyme alone is insufficient to explain the resistance rates. Therefore, the association between the development of resistance and the presence of the enzyme and other components should be investigated further.
Keywords: Acinetobacter baumannii; aminoglycoside-modifying enzymes; resistance.
Similar articles
-
Molecular identification of aminoglycoside-modifying enzymes in clinical isolates of Escherichia coli resistant to amoxicillin/clavulanic acid isolated in Spain.Int J Antimicrob Agents. 2015 Aug;46(2):157-63. doi: 10.1016/j.ijantimicag.2015.03.008. Epub 2015 Apr 29. Int J Antimicrob Agents. 2015. PMID: 26022930
-
Co-occurrence of carbapenem and aminoglycoside resistance genes among multidrug-resistant clinical isolates of Acinetobacter baumannii from Cracow, Poland.Med Sci Monit Basic Res. 2014 Jan 27;20:9-14. doi: 10.12659/MSMBR.889811. Med Sci Monit Basic Res. 2014. PMID: 24463791 Free PMC article.
-
Prevalence of carbapenemases among high-level aminoglycoside-resistant Acinetobacter baumannii isolates in a university hospital in China.Exp Ther Med. 2016 Dec;12(6):3642-3652. doi: 10.3892/etm.2016.3828. Epub 2016 Oct 20. Exp Ther Med. 2016. PMID: 28101158 Free PMC article.
-
Aminoglycoside resistance mediated by the bifunctional enzyme 6'-N-aminoglycoside acetyltransferase-2"-O-aminoglycoside phosphotransferase.Front Biosci. 1999 Jan 1;4:D1-8. doi: 10.2741/culebras. Front Biosci. 1999. PMID: 9872730 Review.
-
Distribution of genes encoding tetracycline resistance and aminoglycoside modifying enzymes in Staphylococcus aureus strains isolated from a burn center.Ann Burns Fire Disasters. 2013 Jun 30;26(2):76-80. Ann Burns Fire Disasters. 2013. PMID: 24133400 Free PMC article. Review.
Cited by
-
Antibiotic resistance of pathogenic Acinetobacter species and emerging combination therapy.J Microbiol. 2017 Nov;55(11):837-849. doi: 10.1007/s12275-017-7288-4. Epub 2017 Oct 27. J Microbiol. 2017. PMID: 29076065 Review.
-
Frequency of 16S rRNA Methylase and Aminoglycoside-Modifying Enzyme Genes among Clinical Isolates of Acinetobacter baumannii in Iran.Iran J Pathol. 2017 Fall;12(4):329-338. Epub 2017 Oct 1. Iran J Pathol. 2017. PMID: 29563928 Free PMC article.
References
-
- Miller GH, Sabatelli FJ, Napes L, Hare RS, Shaw KJ. The most frequently occurring aminoglycoside resistance mechanisms combined results of surveys in eight regions of the world. The Aminoglycoside Resistance Study Groups. J Chemother. 1995;7(Suppl 2):17–30. - PubMed
-
- Van Looveren M, Goossens H ARPAC Steering Group. Antimicrobial resistance of Acinetobacter spp. in Europe. Clin Microbiol Infect. 2004;10:684–704. - PubMed
-
- Nemec A, Dolzani L, Brisse S, van den Broek P, Dijkshoorn L. Diversity of aminoglycoside resistance genes and their association with class 1 integrons among strains of pan-European Acinetobacter baumannii clones. J Med Microbiol. 2004;53:1233–40. - PubMed
-
- Boo TW, Walsh F, Crowley B. Molecular characterization of carbapenem resistant Acinetobacter species in an Irish university hospital: predominance of Acinetobacter genomic species 3. J Med Microbiol. 2009;58:209–216. - PubMed
LinkOut - more resources
Full Text Sources